Taylor made medication may be soon realized.

Published: 2006-12-28 06:56:00

Updated: 2006-12-28 06:56:00

Prof. Oh Jeong-mi of SNU college of pharmacy found in a joint study with the U. S. NIH and U. S. FDA that a silent polymorphism without amino acid alteration could make changes in the substrate specificity, which provides a possibility for a new leap-up in the taylor-made clinical treatments in t...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK